
Keywords: ایالات متحده آمریکا; Administrative datasets; health policy; end-stage renal disease (ESRD); United States; medical costs; reimbursement rates; dialysis; erythropoietin-stimulating agent (ESA); drug costs; US Renal Data System (USRDS); Medicare; data analysis;